Taysha Gene Therapies (TSHA) Current Deferred Revenue (2022 - 2025)
Taysha Gene Therapies (TSHA) reported Current Deferred Revenue of $5.5 million for Q3 2025, down 53.4% from $11.8 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Current Deferred Revenue (2022 - 2025) Analysis & Trends
At the end of FY2024, Taysha Gene Therapies posted Current Deferred Revenue of $9.77 million, down 46.0% from FY2023.
- By year, Current Deferred Revenue came in at $18.11 million in FY2023 (-46.0%) and $33.56 million in FY2022.
- Five-year quarterly Current Deferred Revenue spans a low of $5.5 million in Q2 2025 and a high of $33.56 million in Q4 2022.
- Year over year, Current Deferred Revenue has now declined in each of the last eight quarters, with an average decline of 46.6% over the last eight quarters.
- Across the past five years, year-over-year decline in Current Deferred Revenue ran from 32.8% in Q2 2024 to 59.6% in Q2 2025.
- Per Business Quant data, the three quarters before Q3 2025 came in at $5.5 million (Q2 2025), $7.5 million (Q1 2025) and $9.77 million (Q4 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Taysha Gene Therapies | 1.58 Bn | 1.58 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | 5.50 Mn |
| Jun 30, 2025 | 5.50 Mn |
| Mar 31, 2025 | 7.50 Mn |
| Dec 31, 2024 | 9.77 Mn |
| Sep 30, 2024 | 11.80 Mn |
| Jun 30, 2024 | 13.60 Mn |
| Mar 31, 2024 | 14.70 Mn |
| Dec 31, 2023 | 18.11 Mn |
| Sep 30, 2023 | 18.80 Mn |
| Jun 30, 2023 | 20.24 Mn |
| Mar 31, 2023 | 28.85 Mn |
| Dec 31, 2022 | 33.56 Mn |
API Access
Taysha Gene Therapies Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();